Newer drug therapies for headache

References

• Rabkin R, et al. The prophylactic value of propranolol in angina pectoris. Am J Cardiol 1966: 18: 370–83
   PubMed Web of Science ®Google Scholar
• Wykes P. The treatment of angina pectoris with coexistent migraine. Practitioner 1968; 200: 702–4
   PubMedGoogle Scholar
• Bekes M, et al. Treatment of migraine with propranolol. Lancet 1968; 2: 980
   PubMed Web of Science ®Google Scholar
• Weber RB, Reinmuth OM. The treatment of migraine with propranolol. Neurology (Minneap) 1972; 22: 366–9
   PubMed Web of Science ®Google Scholar
• Malvea BP, et al. Propranolol prophylaxis of migraine. Headache 1973; 12: 163–7
   PubMed Web of Science ®Google Scholar
• Diamond S, Medina JL. Double blind study of propranolol for migraine prophylaxis. Headache 1976: 16: 24–7
   PubMed Web of Science ®Google Scholar
• Wideroete VT. Propranolol in the treatment of migraine. Br Med J 1974; 2: 699–701
   PubMedGoogle Scholar
• Ludvigsson J. Propranolol in treatment of migraine in children. (Letter) Lancet 1973: 2: 799
   PubMed Web of Science ®Google Scholar
• Schweizer W. Beta-blockers: present status and future prospects. Baltimore: University Park Press, 1974
   Google Scholar
• Alderman EL, et al. Coronary artery syndromes after sudden propranolol withdrawal. Ann Intern Med 1974; 81: 625–7
   PubMed Web of Science ®Google Scholar
• Wilkinson M, et al. Clonidine in the treatment of migraine at the City Migraine Clinic in patients selected with tyramine. In: Dalessio DJ. et al, eds. Proceedings, International Headache Symposium. Basel, Switzerland: Sandoz, 1971: 219–21
   Google Scholar
• Stensrud P, Sjaastad O. Clonidine (Catapres) double-blind study after long-term treatment with the drug in migraine. Acta Neurol Scand 1976; 53: 233–6
   PubMed Web of Science ®Google Scholar
• Shaw DA, Saunders M. A double-blind comparison of Dixarit and placebo. In: The migraine headache and Dixarit. Proceedings, symposium at Churchill College, Cambridge, England. Bracknell, England: Boehringer Ingelheim. 1972: 54–61
   Google Scholar
• Ryan RE Sr, et al. Double blind study of Clonidine and placebo in the prophylactic treatment of migraine. Headache 1975; 15: 202–10
   PubMed Web of Science ®Google Scholar
• Kosman ME. Evaluation of Clonidine hydrochloride (Catapres): a new antihypertensive agent. JAMA 1975; 233: 174–6
   PubMed Web of Science ®Google Scholar
• Clonidine (Catapres) for hypertension. Med Lett Drugs Ther 1975 May 23; 17: 45
   PubMedGoogle Scholar
• Fanchamps A. Pharmacodynamic principles of anti-migraine therapy. Headache 1975: 15: 79–90
   PubMed Web of Science ®Google Scholar
• Pasquazzi M, Anselmi E. C 105 (Sandomigram) nella terapia della emicrania: esperienza clinica su 30 casi. Roma Rif Med 1974: 88: 267–74
   Google Scholar
• Siwteri F, et al. Migraine as a cyclical disease with latent and overt components: effects of an antaminic drug. Headache 1970; 10: 53–62
   PubMedGoogle Scholar
• Schaer J. BC- 105: a new serotonin antagonist in the treatment of migraine. Headache 1970: 10: 67–73
   PubMedGoogle Scholar
• Arthur GP, Hornabrook RW. The treatment of migraine with BC 105 (pizotifen): a double blind trial. NZ Med J 1971; 73: 5–9
   PubMedGoogle Scholar
• Vaisrub S. The many faces of bromocriptine. JAMA 1976; 235: 2854–5
   PubMed Web of Science ®Google Scholar
• Benedek-Jaszmann LJ, et al. Bromocriptine and the premenstrual syndrome. Eur J Obstet Gynaecol Reprod Biol 1975; 5: 191–2
   Google Scholar
• Horrobin DF. Prolactin: physiology and clinical significance. Lancaster, England: Medical & Technical Publishing Co, 1973
   Google Scholar
• Hockaday JM, et al. Bromocriptine in migraine. Headache 1976; 16: 109–14
   PubMed Web of Science ®Google Scholar
• Anthony M, Lance JW. Monoamine oxidase inhibitors in the control of migraine. Proc Aust Assoc Neurol 1970: 7: 45–7
   PubMedGoogle Scholar
• Couch JR, et al. Amitriptyline in the prophylaxis of migraine: effectiveness and relationship of antimigraine and antidepressant effects. Neurology (Minneap) 1976: 26: 121–7
   PubMed Web of Science ®Google Scholar
• Multiclinic study group: long-term prophylactic use of Inderal in responsive migraine patients. (To be published)
   Google Scholar
• Hilton BP. Blood platelets: a pathological difference between migraineurs and control subjects. Hemicrania 1971; 3: 3–5
   Google Scholar
• Sandler M. Monoamines and migraine: a path through the woods in vasoactive substances relevant to migraine. In: Diamond S. et al. eds. Vasoactive substances relevant to migraine. Springfield, Ill, Charles C Thomas, 1975: 3–18
   Google Scholar
• Lance JW, et al: Serotonin, the carotid body and cranial vessels in migraine. Arch Neurol 1967; 16: 553–8
   PubMedGoogle Scholar
• Anthony M, et al. The possible relationship of serotonin to the migraine syndrome. Res Clin Stud Headache 1969: 2: 29–59
   Google Scholar
• Deshmukh SV, et al. Platelet dysfunction in migraine: effect of self-medication with aspirin. Thromb Haemost 1976; 36: 319–24
   PubMed Web of Science ®Google Scholar
• Couch JR, Hassanein RS. Platelet aggregability in migraine. Neurology (Minneap) 1977; 27: 643–8
   Google Scholar
• Caen JP, et al. Platelets: physiology and pathology. New York: Stratton Intercontinental Medical Book Corporation, 1977
   Google Scholar
• O'Neill BP, Mann JD. Aspirin prophylaxis in migraine. Lancet 1978; 2: 1179–81
   PubMed Web of Science ®Google Scholar
• Barcia-Marino G. El tratamiento de la Jaqueca y otras cefaleas con dipiridamol. Med Clin (Barc) 1970; 55: 195–200
   Google Scholar
• Horton BT. Histamine cephalgia. Lancet 1952; 72: 92–8
   Google Scholar
• Friedman AP, Mikropoulos HE. Cluster headaches. Neurology (Minneap) 1958; 8: 653–63
   PubMed Web of Science ®Google Scholar
• Jammes JL. The treatment of cluster headaches with prednisone. Dis Nerv Syst 1975; 36: 375–6
   PubMedGoogle Scholar
• Kudrow L. Comparative results of prednisone, methysergide and lithium therapy in cluster headache. In: Greene R, ed. Current concepts in migraine research. New York: Raven Press, 1977: 159–63
   Google Scholar
• Couch JR, Ziegler DK. Prednisone therapy for cluster headache. Headache 1978; 18: 219–21
   PubMed Web of Science ®Google Scholar
• Anthony SM, Lance JW. Histamine and serotonin in cluster headache. Arch Neurol 1971: 25: 225–31
   PubMedGoogle Scholar
• Ekbom K. Lithium in the treatment of chronic cluster headache. (Editorial) Headache 1977; 17: 39–40
   PubMed Web of Science ®Google Scholar
• Kudrow L. Lithium prophylaxis for chronic cluster headache. Headache 1977; 17: 15–8
   PubMed Web of Science ®Google Scholar
• Mathew NT. Clinical subtypes of duster headache and response to lithium therapy. Headache 1978; 18: 27–9
   PubMed Web of Science ®Google Scholar
• Shopson B, et al. Lithium and leukocytosis. Clin Pharmacol Ther 1971; 12: 923–4
   PubMed Web of Science ®Google Scholar
• Geerdink P, et al. Influence of lithium on aggregation, release-reaction, and function of human platelets. Pathol Biol (Paris) 1972 Dec; Suppl: 15–27
   Google Scholar
• Wessels JM, Haanen C. Influence of lithium on function, metabolism and membrane properties of blood platelets. In: Ulitin ON. ed. Platelets: recent advances in basic research and clinical aspects. Proceedings, International Symposium on Blood Platelets, Istanbul, Turkey, Aug 24–7, 1974. Amsterdam: Excerpta Medica, 1975: 192–8
   Google Scholar
• Genefke IK. The active uptake of 5-hydroxytryptamine in rat and human blood platelets under the influence of lithium in vivo and in vitro. Acta Psychiatr Scand 1972; 48: 394–9
   PubMed Web of Science ®Google Scholar
• Genefke IK, Langgard H. Lithium-induced inhibition of the 5-hydroxytryptamine uptake in vitro by rat thrombocytes. Acta Pharmacol Toxicol (Kbh) 1971; 29 Suppl 4: 17
   Google Scholar
• Medina JL, et al. The nature of cluster headache. Headache 1979; 19: 309–22
   PubMed Web of Science ®Google Scholar
• Medina JL, et al. Lithium therapy for cluster headache: changes in platelets, serotonin, and histamine. Arch Neurol (in press)
   Google Scholar
• Kudrow L. Plasma testosterone levels in cluster headache: preliminary results. Headache 1976; 16: 28–31
   PubMed Web of Science ®Google Scholar
• Kudrow L. Plasma testosterone and LH levels in cluster headache. (Abst) Headache 1977: 17: 91
   Google Scholar
• Edelfors S, Gothgen I. Distribution of electrolytes within the brain in lithium treated rats. Acta Pharmacol Toxicol (Kbh) 1971: 29 Suppl 4: 11
   Google Scholar
• Sjaastad O, Dale I. Evidence for a new (?) treatable headache entity. Headache 1974; 14: 105–8
   PubMed Web of Science ®Google Scholar
• Sjaastad O, Dale I. A new (?) clinical headache entity ‘chronic paroxysmal hemicrania.’ 2. Acta Neurol Scand 1976; 54: 140–59
   PubMed Web of Science ®Google Scholar
• Sjaastad O, et al. Chronic paroxysmal hemicranias, a cluster headache variant: some new observations. In: Sicuteri F, ed. Headache: new vistas. Florence, Italy: Biomedical Press, 1977: 123–37
   Google Scholar
• Diamond S, Medina J. Benign exertional headache. Scientific exhibition, annual meeting of the American Association for the Study of Headache, Boston, Jun 1979
   Google Scholar
• Sicuteri F, et al. Termination of migraine headache by a new anti-inflammatory vasoconstrictor agent. Clin Pharmacol Ther 1965: 6: 336–44
   PubMed Web of Science ®Google Scholar
• Diamond S, Baltes BJ. Chronic tension headache treated with amitriptyline: a double-blind study. Headache 1971; 11: 110–6
   PubMed Web of Science ®Google Scholar
• Kudrow L. Tension headache (scalp muscle contraction headache). In: Appenzeller O, ed. Pathogenesis and treatment of headache. New York: Spectrum, 1976: 81–92
   Google Scholar
• Maas JW. Biogenic amines and depression: biochemical and pharmacological separation of two types of depression. Arch Gen Psychiatry 1975; 32: 1357–61
   PubMed Web of Science ®Google Scholar
• Shopsin B, et al. Parachlorophenylalanine reversal of tranylcypromine effects in depressed patients. Arch Gen Psychiatry 1976; 33: 811–9
   PubMed Web of Science ®Google Scholar